Under hypoxia, effective concentration of α-KG is decreased, and the 2-HG level is increased via metabolic reprogramming, thus contributing to the inhibition of α-KG-dependent KDM6A, which is related to cellular heterogeneity, cancer resistance, and progression (20). Here, KDM6A is linked to cancer.